Partecipanti: Dr. Cairo’s biosketch, Stefano Cairo is a molecular biologist with a Ph.D. in Human Genetics (2004). He is currently Head of the Research and Development department at XenTech, a French biotech created in 2006 as spin-off of Institut Curie and specialized in preclinical oncology research and services., His current research is focused on the development and improvement of preclinical in vitro and in vivo tumor models to allow the identification of novel therapeutic strategies as well as the repositioning of current treatments through the identification of biomarkers predictive of tumor response to treatment, with particular focus on triple negative breast cancer and pediatric liver tumors.
Siete invitati al seminario del Dr. Stefano Cairo di XenTech del titolo:
Patient-derived tumor xenografts: instructions for use
&
Improving drug development in oncology through preclinical research
Che si terrà il giorno giovedi 14 Febbraio alle 14.30 in Aula Murri al San’Orsola (polo didattico medicina, pad. 25-27).
Il Dr. Cairo ci parlerà delle sue ricerche in ambito oncologico tramite utilizzo di modelli PDX. Qui sotto un suo breve biosketch, in allegato la locandina dell’evento.